65044-0854 NDC - POLLENS - GRASSES, SOUTHERN GRASS MIX

Drug Information

Product NDC: 65044-0854

Proprietary Name: Pollens - Grasses, Southern Grass Mix

Non Proprietary Name: Pollens - Grasses, Southern Grass Mix

Active Ingredient(s):
  • 100000 [BAU]/mL AGROSTIS GIGANTEA POLLEN;
  • 100000 [BAU]/mL ANTHOXANTHUM ODORATUM POLLEN;
  • 10000 [BAU]/mL CYNODON DACTYLON POLLEN;
  • 100000 [BAU]/mL DACTYLIS GLOMERATA POLLEN;
  • 100000 [BAU]/mL PHLEUM PRATENSE POLLEN;
  • 100000 [BAU]/mL POA PRATENSIS POLLEN;
  • .05 g/mL SORGHUM HALEPENSE POLLEN


Administration Route(s): PERCUTANEOUS; SUBCUTANEOUS

Dosage Form(s): INJECTION, SOLUTION

Pharmacy Class(es):
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Non-Standardized Pollen Allergenic Extract [EPC];
  • Non-Standardized Pollen Allergenic Extract [EPC];
  • Pollen [CS];
  • Pollen [CS];
  • Pollen [CS];
  • Pollen [CS];
  • Pollen [CS];
  • Pollen [CS];
  • Pollen [CS];
  • Standardized Pollen Allergenic Extract [EPC];
  • Standardized Pollen Allergenic Extract [EPC];
  • Standardized Pollen Allergenic Extract [EPC];
  • Standardized Pollen Allergenic Extract [EPC];
  • Standardized Pollen Allergenic Extract [EPC];
  • Standardized Pollen Allergenic Extract [EPC]

Labeler Information

Labeler Name: Jubilant HollisterStier LLC
Product Type: NON-STANDARDIZED ALLERGENIC
FDA Application Number: BLA103888
Marketing Category: BLA
Start Marketing Date:4/19/1941

Package Information

No. Package Code Package Description Billing Unit
165044-0854-210 mL in 1 VIAL (65044-0854-2)
265044-0854-330 mL in 1 VIAL (65044-0854-3)
365044-0854-450 mL in 1 VIAL (65044-0854-4)

NDC Record

Field Name Field Value Definition
PRODUCT NDC65044-0854The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMENON-STANDARDIZED ALLERGENICIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEPollens - Grasses, Southern Grass MixThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEPollens - Grasses, Southern Grass MixThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMEINJECTION, SOLUTIONThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEPERCUTANEOUS; SUBCUTANEOUSThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE4/19/1941This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEBLAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERBLA103888This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEJubilant HollisterStier LLCName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEAGROSTIS GIGANTEA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN; SORGHUM HALEPENSE POLLENAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH100000; 100000; 10000; 100000; 100000; 100000; .05 
ACTIVE INGRED UNIT[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; g/mL 
PHARM CLASSESAllergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023